Holen Sie sich die Stockscreener-App
20.96
4.60%
-1.11
Handel nachbörslich:
20.96
Schlusskurs vom Vortag:
$22.07
Offen:
$21.8
24-Stunden-Volumen:
370.70K
Relative Volume:
2.15
Marktkapitalisierung:
$1.42B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-143.59M
KGV:
-7.4231
EPS:
-2.8236
Netto-Cashflow:
$-119.47M
1W Leistung:
-6.17%
1M Leistung:
-9.25%
6M Leistung:
+66.84%
1J Leistung:
+2.41%
1-Tages-Spanne:
$20.70
$21.93
1-Wochen-Bereich:
$20.70
$23.62
52-Wochen-Spanne:
$11.51
$26.33
Pharvaris Nv Stock (PHVS) Company Profile
Vergleichen Sie PHVS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PHVS
Pharvaris Nv
|
20.96 | 1.42B | 0 | -143.59M | -119.47M | -2.8236 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Pharvaris Nv Stock (PHVS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-09 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2025-06-11 | Eingeleitet | Guggenheim | Buy |
| 2025-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-09-25 | Eingeleitet | Wedbush | Outperform |
| 2023-08-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-05 | Eingeleitet | Bryan Garnier | Buy |
| 2022-09-13 | Fortgesetzt | JMP Securities | Mkt Outperform |
| 2022-08-23 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-22 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-05-25 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-03-02 | Eingeleitet | BofA Securities | Neutral |
| 2021-03-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-03-02 | Eingeleitet | Oppenheimer | Outperform |
| 2021-03-02 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Pharvaris Nv Aktie (PHVS) Neueste Nachrichten
Will Pharvaris N.V. stock attract ESG investorsJuly 2025 Pullbacks & Verified Chart Pattern Signals - newser.com
Has Pharvaris N.V. found a price floorPortfolio Risk Report & Safe Entry Zone Tips - newser.com
Can Pharvaris N.V. stock sustain free cash flow growthJuly 2025 Reactions & Growth Focused Stock Reports - newser.com
What analyst consensus says on Pharvaris N.V. stockEarnings Recap Report & Capital Efficient Trade Techniques - newser.com
What data driven models say about Pharvaris N.V.’s futureJuly 2025 Final Week & Free Community Consensus Stock Picks - newser.com
What’s next for Pharvaris N.V. stock price2025 Trading Recap & AI Forecasted Entry/Exit Points - newser.com
Can Pharvaris N.V. stock deliver sustainable ROEInsider Selling & AI Powered Market Trend Analysis - newser.com
Visual analytics tools that track Pharvaris N.V. performanceProfit Target & AI Enhanced Trading Alerts - newser.com
Pharvaris (NASDAQ:PHVS) Upgraded at Bank of America - Defense World
How to escape a deep drawdown in Pharvaris N.V.Weekly Investment Report & Verified Momentum Watchlists - newser.com
Will Pharvaris N.V. (9EN) stock outperform benchmarksJuly 2025 Action & Verified Swing Trading Watchlist - newser.com
Pharvaris (NASDAQ:PHVS) Raised to Neutral at Bank of America - MarketBeat
Weiss Ratings Reiterates Sell (D-) Rating for Pharvaris (NASDAQ:PHVS) - MarketBeat
Chart based exit strategy for Pharvaris N.V.Market Movers & Verified Technical Signals - newser.com
B of A Securities Upgrades Pharvaris N.V. (PHVS) - Nasdaq
Building trade automation scripts for Pharvaris N.V.2025 Price Targets & Weekly High Return Stock Opportunities - newser.com
BofA Securities upgrades Pharvaris stock rating to Neutral on broader label potential - Investing.com Australia
Pharvaris NV (NASDAQ: PHVS) stock has achieved $25.44 in the past week - fostersleader.com
What drives Pharvaris NV stock priceHigh Yield Income Stocks & Fast Profit Trading Ideas - earlytimes.in
Is Pharvaris NV a good long term investmentTrendline Breakouts & Exceptional Return Stocks - earlytimes.in
Analyzing Pharvaris N.V. with multi timeframe chartsEarnings Growth Summary & Low Drawdown Investment Ideas - newser.com
How to forecast Pharvaris N.V. trends using time seriesTrade Volume Summary & High Accuracy Trade Signal Alerts - newser.com
Why pension funds invest in Pharvaris N.V. (9EN) stock2025 Major Catalysts & Verified High Yield Trade Plans - newser.com
Combining price and volume data for Pharvaris N.V.July 2025 Breakouts & Weekly Watchlist of Top Performers - newser.com
Pharvaris (NASDAQ:PHVS) Shares Gap DownHere's What Happened - MarketBeat
Using Bollinger Bands to evaluate Pharvaris N.V.Share Buyback & Growth Focused Stock Reports - newser.com
Heatmap analysis for Pharvaris N.V. and competitors2025 Big Picture & Verified Entry Point Signals - newser.com
Is Pharvaris N.V. meeting your algorithmic filter criteria2025 Volatility Report & Risk Managed Investment Signals - newser.com
Is Pharvaris N.V. stock supported by strong cash flowsWeekly Trend Report & Low Risk High Reward Trade Ideas - newser.com
Can Pharvaris N.V. hit a new high this monthInsider Selling & Low Risk High Win Rate Stock Picks - newser.com
Will RAPIDe-3 Data Cement Deucrictibant's Role In HAE Treatment? - RTTNews
Pharvaris (NASDAQ:PHVS) Sees Large Volume IncreaseTime to Buy? - MarketBeat
Finanzdaten der Pharvaris Nv-Aktie (PHVS)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):